Developing Point-of-Care Tests for Sexually Transmitted Diseases: An Opportunity for the Diagnostics Industry

2,251 views

|

September 9, 2014

The need to develop acceptable, available point-of-care tests (POCTs) for diagnosing sexually transmitted diseases (STDs) for all at-risk populations is significant. Five of the top ten reportable diseases in the United States are STDs. There are about 20 million new STDs per year and direct costs to the U.S. healthcare system for STDs are over $16 billion per year (CDC's new estimates, February 2013). Stigma, privacy, and confidentiality issues make STDs optimal areas for point-of-care tests at healthcare facilities and for over-the-counter (OTC) assays performed at home.

DiagnosticsMass SpectrometryPersonalized Medicine

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.